Therapy News and Research

RSS

Study reveals damaging role of immune system in severe brain infection

A new study has detailed the damaging role played by the immune system in a severe brain condition most commonly caused by the cold sore virus.

15 Sep 2020

UIC researchers to develop, test a voice-enabled AI virtual agent to deliver mental health care

Researchers at University of Illinois Chicago are studying a novel approach to delivering care to those with moderate depression and anxiety: through artificial intelligence, or AI.

15 Sep 2020

3D cluster of cells could enhance myocardial repair

Cell therapy for cardiac regeneration, while promising, has been hampered by issues with long-term survival of the transplanted cells.

15 Sep 2020

New strategies may be needed to reduce risk of falls in Alzheimer’s patients

To better understand why people without cognitive symptoms are at risk of falling, first author Audrey Kelemen, a graduate student in Stark's lab, and colleagues followed 83 people over age 65 for a year.

15 Sep 2020

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their medicine as prescribed, say Henry Ford Health System dermatology researchers in a study published in the Journal of the American Academy of Dermatology.

15 Sep 2020

Perio & Cardio educational campaign outlines the link between periodontal and heart health

Patients with gum disease should be told that they have a higher risk of suffering cardiovascular diseases - including myocardial infarction and stroke - and that they should actively manage risk factors such as smoking, lack of exercise, excess weight, blood pressure, and a diet high in saturated fats and refined sugars.

15 Sep 2020

CERN and CHUV team up to develop conceptual design of innovative radiotherapy facility

Geneva and Lausanne. CERN and the Lausanne University Hospital, in Switzerland, are collaborating to develop the conceptual design of an innovative radiotherapy facility, used for cancer treatment.

15 Sep 2020

Scientists unlock crucial molecular details regarding tau's activity

Frontotemporal lobar degeneration (FTLD) is a type of dementia that appears earlier in life than Alzheimer's disease (AD).

15 Sep 2020

New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy

Prostate cancer is the most common type of cancer among European men; its incidence surpasses 100 cases per 100,000 people.

15 Sep 2020

Biologic therapy for psoriasis could lead to significant reduction in heart disease

Patients with psoriasis treated with biologic therapy, which are protein-based infusions to suppress inflammation, had a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research published today in Circulation: Cardiovascular Imaging, an American Heart Association journal.

15 Sep 2020

RCas9 gene therapy clears toxic RNA buildup in mouse model of myotonic dystrophy

Myotonic dystrophy type I is the most common type of adult-onset muscular dystrophy. People with the condition inherit repeated DNA segments that lead to the toxic buildup of repetitive RNA, the messenger that carries a gene's recipe to the cell's protein-making machinery.

14 Sep 2020

Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer

A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.

14 Sep 2020

Rheumatology providers and patient advocates urge lawmakers to address healthcare challenges

The American College of Rheumatology will hold its first virtual Advocates for Arthritis event on Tuesday, Sept. 15, where more than 120 rheumatologists, rheumatology health professionals, and patient advocates will meet with lawmakers via video to discuss the healthcare challenges they are facing in the midst of COVID-19.

14 Sep 2020

Tiny antibody component shows high potency in SARS-CoV-2 animal models

University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.

14 Sep 2020

Research finds genetic factors that protect from chronification of migraines

According to existing estimates, migraine is a highly prevalent ailment, with about 15 percent of global population suffering from it at one time or another.

14 Sep 2020

Earlier treatment with steroids reduces adverse outcomes in patients with septic shock

Some critically ill patients with septic shock need medications called vasopressors to correct dangerously low blood pressure.

14 Sep 2020

UofL receives $11.5 million to accelerate the development of new immunotherapies

Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other state and killing more than 600,000 people each year in the U.S. alone.

14 Sep 2020

Researchers develop new PET imaging agent that spotlights inflammation

Many of the most common diseases -- cancer, diabetes, cardiovascular and lung disease, and even COVID-19 -- have been linked to chronic or excessive inflammation.

14 Sep 2020

Measuring brainwaves produced during REM sleep can predict patients response to treatment from depression

Scientists have discovered that measuring brainwaves produced during REM sleep can predict whether a patient will respond to treatment from depression.

14 Sep 2020

International trial of blood thinners for COVID-19 treatment begins

These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new data on the safety and efficacy of these drugs in the treatment of active and convalescent COVID-19 treatment.

13 Sep 2020

Therapy News and Research

Study reveals damaging role of immune system in severe brain infection

UIC researchers to develop, test a voice-enabled AI virtual agent to deliver mental health care

3D cluster of cells could enhance myocardial repair

New strategies may be needed to reduce risk of falls in Alzheimer’s patients

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Perio & Cardio educational campaign outlines the link between periodontal and heart health

CERN and CHUV team up to develop conceptual design of innovative radiotherapy facility

Scientists unlock crucial molecular details regarding tau's activity

New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy

Biologic therapy for psoriasis could lead to significant reduction in heart disease

RCas9 gene therapy clears toxic RNA buildup in mouse model of myotonic dystrophy

Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer

Rheumatology providers and patient advocates urge lawmakers to address healthcare challenges

Tiny antibody component shows high potency in SARS-CoV-2 animal models

Research finds genetic factors that protect from chronification of migraines

Earlier treatment with steroids reduces adverse outcomes in patients with septic shock

UofL receives $11.5 million to accelerate the development of new immunotherapies

Researchers develop new PET imaging agent that spotlights inflammation

Measuring brainwaves produced during REM sleep can predict patients response to treatment from depression

International trial of blood thinners for COVID-19 treatment begins

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News